[Federal Register Volume 74, Number 60 (Tuesday, March 31, 2009)]
[Notices]
[Pages 14563-14564]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7225]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Diagnosis and Treatment of Hereditary 
Hemochromatosis, Potential Extramural Project (PEP) 2009-R-04

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 2 p.m.-4 p.m., May 18, 2009 (Closed)
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Diagnosis and Treatment of 
Hereditary Hemochromatosis, PEP 2009-R-04.''
    For Further Information Contact: Linda L. Shelton, Public Health 
Analyst, Coordinating Center for Health and Information Service,

[[Page 14564]]

Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, 
Atlanta, GA 30333, Telephone (404) 498-1194.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 23, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E9-7225 Filed 3-30-09; 8:45 am]
BILLING CODE 4163-18-P